Drug Type Small molecule drug |
Synonyms BI 144807 |
Target |
Mechanism CCR3 antagonists(C-C chemokine receptor type 3 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Wet age-related macular degeneration | Phase 2 | AT | 01 Jun 2014 | |
Wet age-related macular degeneration | Phase 2 | DE | 01 Jun 2014 | |
Wet age-related macular degeneration | Phase 2 | HU | 01 Jun 2014 | |
Wet Macular Degeneration | Phase 2 | AT | 01 Jun 2014 | |
Wet Macular Degeneration | Phase 2 | DE | 01 Jun 2014 | |
Wet Macular Degeneration | Phase 2 | HU | 01 Jun 2014 | |
Asthma | Phase 1 | GB | 01 Jul 2012 |
Phase 2 | 14 | tjssqkylrg(uqjmxpqfhh) = hyqewbzfgz twpoecjqrp (inolrfjhuv, gjpmeesxzz - wzpnnxyufn) View more | - | 27 Jun 2016 |